Welcome to our dedicated page for American Exceptionalism Acquisition A SEC filings (Ticker: AEXA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Exceptionalism Acquisition Corp. A filings document the SPAC's formation as a Cayman Islands blank-check company, its NYSE-listed Class A ordinary shares and the capital structure established around its initial public offering. The 8-K record covers the IPO closing, sponsor private placement shares issued to AEXA Sponsor LLC, proceeds placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company as trustee, and an audited balance sheet reflecting the offering proceeds.
AEXA Sponsor LLC, SC SPAC Holdings LLC, and Chamath Palihapitiya filed a Schedule 13G reporting beneficial ownership in American Exceptionalism Acquisition Corp. A. The group reports 14,660,714 Class A Ordinary Shares, representing 29.6% of the class, with shared voting and dispositive power over the same amount.
The reported stake consists of 175,000 Class A shares and 14,485,714 Class A shares issuable upon conversion of Class B shares on a one-for-one basis, subject to conditions tied to the company’s initial business combination, share-price performance thresholds, or a change of control. The calculation of ownership uses an assumed total of 49,460,714 Class A shares, combining 34,675,000 Class A shares outstanding as of November 14, 2025 with 14,785,714 issuable upon conversion of all outstanding Class B shares. The Sponsor is the record holder; Mr. Palihapitiya and SC SPAC Holdings may be deemed to beneficially own the shares through control interests and each disclaims beneficial ownership except to the extent of pecuniary interest.
American Exceptionalism Acquisition Corp. A reported its first quarterly results as a newly public SPAC and detailed the close of its Initial Public Offering. On September 29, 2025, the company sold 34,500,000 Class A ordinary shares at $10.00 per share, including the full over‑allotment, for $345,000,000, and sold 175,000 private placement shares for $1,750,000. Proceeds were placed in a trust account intended for a future business combination.
The company recorded a net loss of $10,423,509 for the period from July 11, 2025 (inception) through September 30, 2025, driven primarily by a recorded advisory fee expense of $10,350,000. Cash outside the trust was $882,421, and 34,500,000 Class A shares are classified as redeemable at approximately $10.00 per share. Deferred underwriting fees totaled $10,350,000. As of November 14, 2025, there were 34,675,000 Class A and 14,785,714 Class B shares outstanding.
Management disclosed substantial doubt about the company’s ability to continue as a going concern without completing a business combination within the stated completion window or obtaining additional financing.
American Exceptionalism Acquisition Corp. A (AEXA) received a Schedule 13G from The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC disclosing beneficial ownership of 2,011,370 Class A ordinary shares, representing 5.8% of the class as of the event date 09/30/2025.
The filing reports 0 shares with sole voting and dispositive power and 2,011,370 shares with shared voting and dispositive power. The reporting persons classify as HC, CO (parent holding company/control person) and BD, OO, IA (broker-dealer, other, investment adviser). The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
American Exceptionalism Acquisition Corp. A completed its initial public offering of 34,500,000 Class A ordinary shares at $10.00 per share, including 4,500,000 shares issued from the underwriters’ over-allotment option, generating $345,000,000 in gross proceeds.
Concurrently, the sponsor purchased 175,000 private placement shares at $10.00 for $1,750,000. A total of $345,000,000, comprised of proceeds from the IPO and the private placement, was deposited into a U.S.-based trust account at JP Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company as trustee. An audited balance sheet as of September 29, 2025 is included as Exhibit 99.1.